Yang Alex Keun Mo's Form 4 filing
Polaryx Therapeutics, Inc. (PLYX) · filed May 28, 2026
- Accession no.
- 0001213900-26-062322
- Filed
- May 28, 2026, 8:00 PM ET
- Trade date
- May 27, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $360.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yang Alex Keun MoCIK 0002103399 | Director, Officer (Chief Executive Officer), 10% Owner |
| Mstone Partners Healthcare LtdCIK 0002104809 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | Common Stock | PPurchaseAcquired | +88,453 | $4.07 | +$360,003.71 | 24,233,249 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.